Glycerolyte 57 Solution 124.2 mg (Sodium Phosphate Dibasic SOLUTION) 124.2 MG

Glycerolyte 57 Solution is a sodium phosphate dibasic formulation designed for medical use. This 400ml solution, manufactured by Fresenius Kabi AG, is commonly utilized in clinical settings for specific therapeutic purposes.

Strength

124.2 MG

Pack Size

400ML

Manufacturer / TM Owner

FRESENIUS KABI AG

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Glycerolyte 57 Solution is primarily used in medical procedures to prepare the bowels for certain diagnostic tests or surgeries. It works by cleansing the intestines to ensure clear visibility. This solution is often administered under medical supervision to achieve the desired results.

Side Effects

When used as directed, Glycerolyte 57 Solution may cause temporary discomfort such as abdominal cramping or bloating. Some individuals might experience nausea or diarrhea. These effects are generally short-lived and subside once the procedure is complete.

Precautions & Warnings

It is important to follow the instructions provided by healthcare professionals when using Glycerolyte 57 Solution. Patients should inform their healthcare provider about any existing medical conditions or allergies. Proper hydration is crucial before and after administration to minimize potential side effects.

Avoid Interactions

Glycerolyte 57 Solution may interact with certain medications or supplements. It is advisable to consult a healthcare provider before using this solution if you are taking other medications. Alcohol and other substances that affect the gastrointestinal tract should be avoided during the treatment period.

Frequently Asked Questions

Glycerolyte 57 Solution is used to cleanse the bowels in preparation for diagnostic tests or surgical procedures.

This solution is typically administered under medical supervision, following specific guidelines provided by healthcare professionals.

Common side effects may include abdominal cramping, bloating, nausea, and diarrhea, which are usually temporary.

It is important to consult a healthcare provider before using Glycerolyte 57 Solution with other medications to avoid potential interactions.

Patients should inform their healthcare provider about any existing medical conditions or allergies and maintain proper hydration before and after administration.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.